Cancer clinical trials in the region Occitanie
174 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Breast cancer
#NCT05563220
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Hormone therapy
1
2
Chemotherapy
7 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse), Centre de Cancérologie du Grand Montpellier (Montpellier)
Stemline Therapeutics, Inc.
Phase 2
Liver and bile duct cancer
#NCT05528952
Hepatocellular carcinoma
Locally Advanced
Metastatic
Systemic Treatment-Naive
None
Unhealthy
A
Immunotherapy
8 main criterias to confirm
Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier)
CHU de Besançon
Phase 2
Lung cancer
#NCT05384626
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ALK
Immunotherapy
Chemotherapy
Targeted therapy
1
2
3 or more
Systemic Treatment-Naive
7 main criterias to confirm
IUCT Oncopôle (Toulouse)
Nuvalent Inc.
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05384626
Locally Advanced
Metastatic
Metastatic Castration-resistant
ALK
1
2
3 or more
AKT
ATM
BRAF
BRCA 1/2
CDK12
CHEK 1/2
ESR
FGFR
HER2
HOXB13
KRAS G12C
KRAS non G12C
MET
MSI/dMMR
NRAS
NTRK-1/2/3
PALB2
PIK3CA
PTEN
RET
Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
Nuvalent Inc.
Phase 2
Liver and bile duct cancer
#NCT05325866
Intrahepatic cholangiocarcinoma
Locally Advanced
Metastatic
FGFR
1
2
3 or more
Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Amgen
Phase 2
Lung cancer
#NCT05325866
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
FGFR
Immunotherapy
Chemotherapy
Targeted therapy
1
2
3 or more
Systemic Treatment-Naive
7 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Amgen
Phase 2
Breast cancer
#NCT05325866
HER2 Negative
HR Negative
Locally Advanced
Metastatic
FGFR
2
3 or more
Systemic Treatment-Naive
7 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Amgen
Phase 2
Breast cancer
#NCT05297617
HER2 Negative
HR Positive
Localized
Surgery
Hormone therapy
None
Chemotherapy
7 main criterias to confirm
Clinique des Cèdres - Ramsay Santé (Cornebarrieu)
UNICANCER
Phase 2
Breast cancer
#NCT05296746
HER2 Negative
HR Positive
Locally Advanced
Systemic Treatment-Naive
Systemic Treatment-Naive
None
7 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut Sainte Catherine (Avignon)
Novartis
Phase 2
Lung cancer
#NCT05142696
SCLC (Small Cell Lung Cancer)
Locally Advanced
Metastatic
Systemic Treatment-Naive
None
Immunotherapy
6 main criterias to confirm
Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier)
Novartis